"Science thrives when diverse minds collide. Nexogen is that collision"

–Prof. Alessandro Conti

At Nexogen ImmunoTech, we believe no one should live in fear of the next outbreak. Our mission is to redefine disease prevention through next-generation universal vaccines—bridging cutting-edge science with global health equity.

Why We Exist

For the Vulnerable

1. • 500K annual deaths from flu alone—despite seasonal vaccines.

   • Livestock outbreaks threaten food security for billions.

For the Future

• Pathogens evolve faster than traditional R&D cycles.

• Climate change accelerates zoonotic spillover risks.

For Equity

• Universal vaccines simplify distribution to low-resource regions.

• No more "strain guessing" leaving populations unprotected.

The Birth of a breakthrough

Our revolutionary platform was born in Prof. Alessandro Conti’s lab at the European Institute of Advanced Immunology, where a multidisciplinary team—led by Dr. Priyanka Iyer (antigen design) and Dr. Florian Schreiber (nanoparticle delivery)—cracked the code for broad-spectrum immunity.

• 2018: Discovery of conserved epitopes in influenza strains.

• 2020: Proof-of-concept nanoparticle assembly (published in Science).

• 2022: Spinout from academia with Series A backing.

Today, that foundational work has evolved into a platform capable of outpacing viral evolution—and a team united by one goal: making pandemics obsolete.

What Drives Us

• Innovation: Harnessing cutting-edge biotechnology and molecular science to create vaccines that adapt to evolving pathogens.

• Global Impact: Bridging the gap between human and veterinary medicine to foster healthier populations and ecosystems.

• Accessibility: Committing to equitable vaccine solutions that reach communities and farmers everywhere, regardless of geography or resources.

• Collaboration: Partnering with scientific leaders, healthcare providers, and agricultural experts to accelerate breakthroughs.

Our Vision

We envision a world where universal vaccines eliminate the threat of infectious diseases across species, empowering humanity and agriculture to thrive in harmony. At Nexogen ImmunoTech, we’re not just developing vaccines — we’re building a healthier, more resilient future for a